Compare Ecopetrol SA (EC) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ecopetrol SA vs Hinge Health Inc. Class A Common Stock — how do they compare? Ecopetrol SA trades at $17.93 (market cap $34.63B), while Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B). The key difference: Ecopetrol SA is far larger — about 4.1× Hinge Health Inc. Class A Common Stock's market cap, and Ecopetrol SA pays a 3.63% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ecopetrol SA for 84 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| EC | HNGE | |
|---|---|---|
Market Cap | $34.63B | $8.47B |
Volume | 1,833,096 | 1,624,526 |
Sector | Energy | Health |
52-Week High | $18.26 | $105.14 |
52-Week Low | $8.61 | $31.17 |
Typical Hold Time | 84 Days | 0 Days |
Enterprise Value | $63.33B | $8.09B |
Dividend Yield | 3.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ecopetrol (EC) trades at $17.52, up 1.68% with a bullish technical signal despite recent earnings misses. The stock shows attractive valuation metrics with P/E of 8.27 and P/S of 0.94, though revenue has declined from $159.6B in 2022 to $119.7B in 2025. Recent management changes and board restructuring signal corporate transformation efforts amid ongoing operational challenges.
While valuation appears compelling, declining revenue trends and mixed analyst sentiment (27% buy, 55% hold) suggest cautious optimism. The $16.85 consensus target implies downside risk, with key catalysts including new CEO leadership execution and potential operational turnaround. Oil price volatility and Colombian political dynamics remain significant risk factors.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ecopetrol SA
Ecopetrol SA is a vertically integrated oil company with operations in Latin America and the United States Gulf Coast. Based out of Colombia, the company explores, develops, and conducts production activities in various countries. Ecopetrol works as the primary operator or partner in a joint venture, in a host of assets held onshore and offshore. Along with production, the company refines and markets crude oils and byproducts produced from its fields. Crude products are moved by Ecopetrol through a series of pipelines throughout Colombia, along with a network of third-party production centers and facilities.
Read more on EC →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
